Disc Medicine (IRON) Reiterated at Buy by Stifel After P3 INSPIRE Results
Tweet Send to a Friend
Stifel analyst Stephen Willey reiterated a Buy rating and $111.00 price target on Disc Medicine (NASDAQ: IRON).The analyst commented, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
